1. 2013: another good year for EJNMMI

   • Ignasi Carrió

   Editorial 31 October 2013 Pages: 1791 - 1793

2. Nuclear medicine 2013: from status quo to status go

   • Thomas Beyer
   • Marcus Hacker
   • Hans-Jürgen Wester

   Editorial 03 October 2013 Pages: 1794 - 1796

3. Could ⁶⁸Ga-somatostatin analogues replace other PET tracers in evaluating extra-adrenal paragangliomas?

   • Giorgio Treglia
   • Luca Giovanella

   Editorial Commentary 27 September 2013 Pages: 1797 - 1799

4. A retrospective comparison between ⁶⁸Ga-DOTA-TOC PET/CT and ¹⁸F-DOPA PET/CT in patients with extra-adrenal paraganglioma

   • Alexander Kroiss
   • Daniel Putzer
   • Irene Johanna Virgolini

   Original Article 27 September 2013 Pages: 1800 - 1808

   

5. ¹⁸F-FDG PET/CT predicts survival in patients with inflammatory breast cancer undergoing neoadjuvant chemotherapy

   • Selin Carkaci
   • Christopher T. Sherman
   • Wei T. Yang

   Original Article 23 July 2013 Pages: 1809 - 1816

   

6. Diagnostic accuracy of ¹⁸F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study

   • Françoise Bonichon
   • Jean Palussière
   • Anne-Laure Cazeau

   Original Article 17 September 2013 Pages: 1817 - 1827

   

7. Pathology-based validation of FDG PET segmentation tools for volume assessment of lymph node metastases from head and neck cancer

   • Dominic A. X. Schinagl
   • Paul N. Span
   • Johannes H. A. M. Kaanders

   Original Article 14 August 2013 Pages: 1828 - 1835

   

8. Total lesion glycolysis by ¹⁸F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcoma

   • Eun-Seok Choi
   • Seung-Gyun Ha
   • Ilkyu Han

   Original Article 24 July 2013 Pages: 1836 - 1842

   

9. Hypocalcaemia after treatment with [¹⁷⁷Lu-DOTA⁰,Tyr³]octreotate

   • Esther I. van Vliet
   • Wouter W. de Herder
   • Dik J. Kwekkeboom

   Original Article 23 July 2013 Pages: 1843 - 1852

   

10. Rapid blood clearance and lack of long-term renal toxicity of ¹⁷⁷Lu-DOTATATE enables shortening of renoprotective amino acid infusion

    • Raghava Kashyap
    • Price Jackson
    • Rodney J. Hicks

    Original Article 18 July 2013 Pages: 1853 - 1860

    

11. Biodistribution and radiation dosimetry in healthy volunteers of a novel tumour-specific probe for PET/CT imaging: BAY 85-8050

    • Kamilla Smolarz
    • Bernd Joachim Krause
    • Markus Schwaiger

    Original Article 23 July 2013 Pages: 1861 - 1868

    

12. Gated SPECT evaluation of left ventricular function using a CZT camera and a fast low-dose clinical protocol: comparison to cardiac magnetic resonance imaging

    • Assuero Giorgetti
    • Pier Giorgio Masci
    • Paolo Marzullo

    Original Article 25 July 2013 Pages: 1869 - 1875

    

13. The amount of viable and dyssynchronous myocardium is associated with response to cardiac resynchronization therapy: initial clinical results using multiparametric ECG-gated [¹⁸F]FDG PET

    • Sebastian Lehner
    • Christopher Uebleis
    • Marcus Hacker

    Original Article 01 August 2013 Pages: 1876 - 1883

    

14. The complementary roles of dynamic contrast-enhanced MRI and ¹⁸F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis

    • Claudia Calcagno
    • Sarayu Ramachandran
    • Zahi A. Fayad

    Original Article 14 August 2013 Pages: 1884 - 1893

    

15. Hybrid CT angiography and quantitative ¹⁵O-water PET for assessment of coronary artery disease: comparison with quantitative coronary angiography

    • Anders Thomassen
    • Henrik Petersen
    • Poul F. Høilund-Carlsen

    Original Article 28 August 2013 Pages: 1894 - 1904

    

16. Insulin resistance is a major determinant of myocardial blood flow impairment in anginal patients

    • Riccardo Liga
    • Daniele Rovai
    • Danilo Neglia

    Original Article 11 September 2013 Pages: 1905 - 1913

    

17. Reduced cardiac ¹²³I-metaiodobenzylguanidine uptake in patients with spinocerebellar ataxia type 2: a comparative study with Parkinson’s disease

    • Anna De Rosa
    • Sabina Pappatà
    • Alberto Cuocolo

    Original Article 09 August 2013 Pages: 1914 - 1921

    

18. Combined ¹⁸F-fluoride and ¹⁸F-FDG PET/CT: a response based on actual data from prospective studies

    • Andrei Iagaru
    • Camila Mosci
    • Sanjiv Sam Gambhir

    Letter to the Editor 21 September 2013 Pages: 1922 - 1924

19. Diet and ¹⁸F bone imaging

    • V. Ralph McCready
    • Sabina Dizdarevic

    Letter to the Editor 27 September 2013 Pages: 1925 - 1925

20. Area under the cumulative SUV-volume histogram is not a viable metric of intratumoral metabolic heterogeneity: further comments

    • Frank J. Brooks

    Letter to the Editor 09 October 2013 Pages: 1926 - 1927

    

21. Multitracer PET imaging of bone metastases from paraganglioma: peripheral halo of uptake on ¹⁸F-FLT PET mismatching with central uptake of ¹⁸F-FDOPA, ¹⁸F-fluorodopamine, and ¹⁸F-FDG

    • Elise M. Blanchet
    • Victoria Martucci
    • Karel Pacak

    Image of the Month 24 July 2013 Pages: 1928 - 1929

    

22. ¹⁸F-Fluoride PET/CT in the detection of bone metastases in clear cell renal cell carcinoma: discordance with bone scintigraphy

    • Chiara Fuccio
    • Elena Giulia Spinapolice
    • Giuseppe Trifirò

    Image of the Month 23 July 2013 Pages: 1930 - 1931

    

23. The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer

    • Francesco Giammarile
    • Naomi Alazraki
    • Sergi Vidal Sicart

    Guidelines 02 October 2013 Pages: 1932 - 1947

24. EANM Springer Prizes awarded at EANM’13 Lyon

    Society Communications 25 October 2013 Pages: 1948 - 1948

    

25. Nuclear medicine training and practice in Spain

    • A. M. Soriano Castrejon
    • E. Prats Rivera
    • J. L. Carreras Delgado

    UEMS/EBNM 01 October 2013 Pages: 1949 - 1951